If you live in the state of Connecticut and have been diagnosed with mesothelioma, you have access to a number of treatment options. Conventional mesothelioma treatments available in Connecticut include surgery, chemotherapy and radiation. Beyond these conventional treatments, clinical trials may currently be recruiting pleural and peritoneal mesothelioma patients in Connecticut.
We have listed top mesothelioma doctors that practice in Connecticut as well as the top cancer care centers in the state. Additionally for caregivers, we have located a number of local cancer treatment support services. Read more about health care options available to you in Connecticut here.
01. Statistics
Connecticut Mesothelioma Statistics
02. Cancer Centers
Connecticut Mesothelioma Cancer Centers
For your convenience, we have compiled a list of mesothelioma cancer centers that are located in Connecticut. Please click on a cancer center link to obtain more information about the clinical programs offered and how to contact the cancer center.
Connecticut Mesothelioma Cancer Clinics
03. Doctors
Doctors who Treat Mesothelioma in Connecticut
For your convenience, we have compiled a list of mesothelioma doctors that are located in Connecticut. Please click on a doctor link to obtain more information about their background, areas of expertise, professional affiliations, and contact information.
Connecticut Mesothelioma Doctors
It is not uncommon for patients to travel outside of their current states to meet with top oncologists and thoracic surgeons across the country. These mesothelioma experts usually have a particular focus within their practice.
04. Clinical Trials
Mesothelioma Clinical Trials in Connecticut
The following clinical trials are in progress or actively recruiting participants in the state of Connecticut:
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Conditions: Carcinoma, Neoplasms, Carcinoma, Squamous Cell, Adenocarcinoma, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Nasopharyngeal Carcinoma, Breast Neoplasms, Cholangiocarcinoma, Carcinoma, Basal Cell, Gastrointestinal Stromal Tumors, Carcinoid Tumor, Carcinoma, Transitional Cell, Carcinoma, Adenoid Cystic, Teratoma, Adenocarcinoma of Lung, Carcinoma, Neuroendocrine, Pheochromocytoma, Seminoma, Choriocarcinoma, Cystadenocarcinoma, Cystadenocarcinoma, Serous, Carcinoma, Endometrioid, Paraganglioma, Chordoma, Hemangiosarcoma, Fibromatosis, Aggressive, Trophoblastic Neoplasms, Adenocarcinoma, Mucinous, Gestational Trophoblastic Disease, Adenocarcinoma, Clear Cell, Nerve Sheath Neoplasms, Neurofibrosarcoma, Thyroid Neoplasms, Fibroma, Cystadenocarcinoma, Mucinous, Pseudomyxoma Peritonei, Vulvar Neoplasms, Sex Cord-Gonadal Stromal Tumors, Adrenocortical Carcinoma, Carcinoma, Islet Cell, Paget Disease, Extramammary, Adenocarcinoma, Papillary, Carcinoma, Acinar Cell, Adenocarcinoma, Bronchiolo-Alveolar, Mixed Tumor, Mullerian, Neoplasms, Unknown Primary, Carcinoma, Giant Cell
Last Updated: September 29, 2020
Status: Recruiting
Locations:
A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors
Conditions: Neoplasms
Last Updated: June 4, 2020
Status: Recruiting
Locations: La Jolla, CA. Sacramento, CA. Stanford, CA. New Haven, CT. Huntersville, NC. Greenville, SC. Dallas, TX. San Antonio, TX. Charlottesville, VA. Fairfax, VA.
Study of SO-C101 and SO-C101in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors
Conditions: Carcinoma, Merkel Cell, Carcinoma, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Carcinoma, Squamous Cell, Ovarian Neoplasms, Carcinoma, Hepatocellular, Stomach Neoplasms, Uterine Cervical Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Small Cell Lung Carcinoma, Mesothelioma, Triple Negative Breast Neoplasms, Squamous Cell Carcinoma of Head and Neck, Biliary Tract Neoplasms, Anus Neoplasms, Thymus Neoplasms, Microsatellite Instability
Last Updated: January 15, 2020
Status: Recruiting
Locations: New Haven, CT. Houston, TX.
05. Support Services
Connecticut Cancer Support Services
While receiving treatment, mesothelioma patients may find a need for temporary lodging, patient transport, physical therapy or counseling. We have compiled a list of these cancer support services in Connecticut for your convenience.
Connecticut Treatment Support Services
-
Counseling & Support Groups
- MISSION
(Southport)
203-292-8722 - Connecticut Counseling Services
(Danbury)
203-743-4698 - Connecticut Counseling Services
(Norwalk)
203-838-6508 - Connecticut Counseling Services
(Waterbury)
203-755-8874 - Ann’s Place
(Danbury)
203-790-6568
- MISSION
-
Long-Term Housing
- Montage Rocky Hill
(Rocky Hill)
860-756-0368 - Atria Stratford
(Stratford)
203-380-0006 - Flats at 390
(Meriden)
203-292-1099
- Montage Rocky Hill
-
Patient Transport
- Andover Dial a Ride
(Andover)
860-742-7305 - Connecticut Transportation Solutions
(Bridgeport)
203-592-7213 - Connecticut Transportation Solutions
(Waterbury)
203-592-7213 - Sweetheart Transportation Service
(Danbury)
203-748-2511
- Andover Dial a Ride
-
Physical Therapy
- Gaylord Physical Therapy, Orthopedics & Sports Medicine
(North Haven)
203-230-9226 - St. Vincent’s Medical Center
(Bridgeport)
203-576-6000 - Griffin Hospital
(Derby)
203-732-7445
- Gaylord Physical Therapy, Orthopedics & Sports Medicine
Asbestos Exposure and Mesothelioma in Connecticut
Asbestos Exposure and Mesothelioma in ConnecticutLegal Options in Connecticut
Legal Options in Connecticut
